Navigation Links
MicroPhage Selects Lynn Taussig, MD for Board of Directors
Date:12/2/2008

LONGMONT, Colo., Dec. 2 /PRNewswire/ -- MicroPhage, Inc., http://www.microphage.com, announced today that Lynn M. Taussig, MD has joined the company's Board of Directors. Taussig was president and CEO of National Jewish Medical and Research Center in Denver, the nation's leading institution for studying respiratory diseases, from 1993 to 2006. His medical specialty is pediatric pulmonology.

"I have followed MicroPhage extensively and am impressed with its progress in developing new, rapid bacterial identification and antibiotic susceptibility tests, and am enthused about the clinical impact their products will have in providing accurate and cost-effective diagnosis of serious infections," said Taussig.

MicroPhage CEO Steve Lundy knows Taussig's expertise in diagnosis and management of respiratory diseases and his healthcare management experience will be valuable to the board in guiding the company's future. "We are pleased to have a physician and hospital executive of Dr. Taussig's stature join our board. His involvement and support shows confidence in MicroPhage, and his clinical expertise and vision will be deeply valued," said Lundy.

Taussig has served on numerous academic, government and business boards and commissions and has authored more than 170 publications related to respiratory illnesses in children. He has earned several academic, civic and professional honors, including the Distinguished Achievement Award from the American Thoracic Society. He currently serves as special advisor to the Provost for Life Sciences at the University of Denver and is on the Board of Directors of the Colorado Biosciences Association.

MicroPhage is in late stage development for its bacterial detection and susceptibility diagnostic system. The first products are targeted for rapid detection of MRSA (methicillin-resistant Staphylococcus aureus) and MSSA (methicillin-sensitive Staphylococcus aureus) for screening and diagnostic applications.

About MicroPhage

Based in Longmont, Colo. and privately held, MicroPhage, Inc. is working to be a global leader in developing rapid diagnostics products for bacterial identification and antibiotic susceptibility/resistance testing. Using its bacteriophage-based amplification platform for immunoassay diagnostics, the company has developed a patented process that is a product platform or engine for rapid, easy-to-use, inexpensive bacterial identification and antibiotic susceptibility testing. Its first products, expected in late 2009, will set a new standard for clinicians in MRSA identification and antibiotic susceptibility testing, and are designed to fit the demands for improving laboratory workflow. For further information, go to http://www.microphage.com.


'/>"/>
SOURCE MicroPhage
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New Research Shows MicroPhage Test Accurately and Rapidly Detects Serious Bacterial Infections
2. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
3. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
4. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
5. West Penn Allegheny Health System Selects Electronic Health Record From Allscripts
6. ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
7. NIH selects Weill Cornell Medical College to lead new NYC translational research collaboration
8. Moffitt Selects Microsofts Azyxxi to Help Drive Personalized Cancer Treatment
9. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
10. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
11. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... serve communities in and around the greater Phoenix metropolitan region, is announcing a ... , The mission of the Homeless Youth Connection is to promote community awareness ...
(Date:12/8/2016)... ... December 08, 2016 , ... Bill ... and business owners in and around central Kansas, is joining the Youth Horizons ... in the region. , Headquartered in Wichita, Youth Horizons works to empower area ...
(Date:12/7/2016)... Wisconsin (PRWEB) , ... December 07, 2016 , ... Kenall ... extraordinary new MedMaster™ MPCNGX . The MPCNGX is a multi-function, sealed, LED luminaire ... right amount of light where and when it’s needed. , A 2’ ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... up with a schizophrenic mother in a unique, personal perspective through animation. ... treating trauma and addictive disorders at her private psychotherapy practice. Sheri’s mother, Pearl, ...
(Date:12/7/2016)... ... December 07, 2016 , ... Castle Dermatology Institute is now offering liquid ... a more youthful appearance to the face. Dr. Peyman Ghasri and Dr. Pedram Ghasri, ... of other treatments, to rejuvenate and renew the facial appearance. , Sculptra is ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 7, 2016  Urinary catheters are used for ... other urological disorders. Urinary catheters include indwelling (Foley) ... Indwelling or Foley catheter is a flexible tube ... catheter is inserted into the bladder through the ... balloon attachment at one end of the catheter ...
(Date:12/7/2016)... YORK , Dec. 7, 2016 Global ... This report on the global hospital linen supply and ... of this market on a global and regional level. ... forecast for the period between 2015 and 2024 based ... the dynamics of the market along with their impact ...
(Date:12/7/2016)... , Dec. 7, 2016 A new investigational drug ... human clinical trials in search of the world,s first treatment ... publication of research findings today in the journal ... will be a watershed moment for millions of people living ... director of Van Andel Research Institute,s Center ...
Breaking Medicine Technology: